Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
US9993467B2 · kind B2 · utility
1Cited by
51References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2015 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Dec 23, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.